S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7121 +0.17%
AFTER HRS · 17:05 ET
Market ClerkRecap
Wed Oct 21 · after hours2 signals today106 insider buys this week · $305.5MCIRO short report next: Oct 31The week ahead

MAZE

Maze Therapeutics, Inc.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
32.67
+0.22 +0.68%
USD · close Oct 21

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $1.8BP/E —DIV YIELD —FCF YIELD -5.89%REV TTM —NET INCOME −$133.6MNET CASH $163.7M52W 22.39 – 51.83NEXT EARNINGS Nov 5 EST.SEC XBRL · TTM TO Invalid Date

What MAZE had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
FiledWhat was reportedEvent dateDocument
Oct 16Material agreementUnregistered share saleOct 15open on EDGAR ↗

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch MAZE. Know when insiders buy.
One email the day a filing lands. Free.